Semaglutide 2 mg, tirzepatide 5 mg, and other dose strengths cannot be compared on a milligram-for-milligram basis
Recent research has provided a clearer picture of how semaglutide affects kidney health and the associated risks of kidney infections
Current Pharmaceutical Design
According to FDAs recommended method for removing duplicate reports, the PRIMARYID, CASEID, and FDA_DT fields of the DEMO table were selected and sorted in the order of CASEID, FDA_DT, and PRIMARYID, and for reports with the same CASEID, the one with the largest FDA_DT value was retained
NEJM STEP trials (2021)
Thus, it appears possible to divorce nausea from satiation in mice treated with GLP-1R agonists by discovery of GLP-1R agonists that preferentially access and activate the NTS but not the AP